Document is current

Article History

Received: 19 September 2024

Accepted: 3 January 2025

First Online: 13 January 2025

Declarations

:

: Gerhard Gründer has served as a consultant for Boehringer Ingelheim, Institute for Quality and Efficiency in Health Care (IQWiG), Janssen-Cilag, Lundbeck, MindMed, Otsuka, Recordati, Roche, ROVI, Sage, and Takeda. He has served on the speakers’ bureau of Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Recordati, and ROVI. He has received grant support from Beckley Psytech and Boehringer Ingelheim. He is co-founder and/or shareholder of Mind and Brain Institute GmbH, OVID Health Systems GmbH and MIND Foundation gGmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflict of interest. Funding: This study is part of a project entitled: “Correlations between systemic inflammation, brain endophenotypes and fatigue in participants with depression”. This project has received a financial support from the German Exchange Academic Program (DAAD). This program included also the financial support of the project, that involved mainly material expenses and participants’ expenses for participation. Additionally, the authors of this project contacted the owner of the “Immunität und Seele” foundation (Prof. Dr. Norbert Müller), that awarded this project and supported financially. Both supporters have no role in the design of the study, data collection, analysis and interpretation of results.

: Ethical approval and consent to participate: This study was approved by the ethic committee of Faculty of Medicine of the Justus Liebig University. Additionally, this study is part of a big project to investigate inflammatory factors and fatigue in patients with depression and multiple sclerosis. The code of this project in the ethic committee is AZ 81/18. Ethical approval and the informed consents in its original language (German) are by request.

: Not applicable.